716 related articles for article (PubMed ID: 22315951)
1. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
[TBL] [Abstract][Full Text] [Related]
2. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
Rajilić-Stojanović M; Biagi E; Heilig HG; Kajander K; Kekkonen RA; Tims S; de Vos WM
Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
[TBL] [Abstract][Full Text] [Related]
3. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.
Parkes GC; Rayment NB; Hudspith BN; Petrovska L; Lomer MC; Brostoff J; Whelan K; Sanderson JD
Neurogastroenterol Motil; 2012 Jan; 24(1):31-9. PubMed ID: 22070725
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
Malinen E; Rinttilä T; Kajander K; Mättö J; Kassinen A; Krogius L; Saarela M; Korpela R; Palva A
Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
[TBL] [Abstract][Full Text] [Related]
5. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
[TBL] [Abstract][Full Text] [Related]
6. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
7. The putative role of the intestinal microbiota in the irritable bowel syndrome.
Collins SM; Denou E; Verdu EF; Bercik P
Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
[TBL] [Abstract][Full Text] [Related]
8. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
[TBL] [Abstract][Full Text] [Related]
9. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
[TBL] [Abstract][Full Text] [Related]
11. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation.
Furnari M; Savarino E; Bruzzone L; Moscatelli A; Gemignani L; Giannini EG; Zentilin P; Dulbecco P; Savarino V
J Gastrointestin Liver Dis; 2012 Jun; 21(2):157-63. PubMed ID: 22720304
[TBL] [Abstract][Full Text] [Related]
13. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome.
Collins S; Verdu E; Denou E; Bercik P
Dig Dis; 2009; 27 Suppl 1():85-9. PubMed ID: 20203502
[TBL] [Abstract][Full Text] [Related]
14. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
Andrews CN; Griffiths TA; Kaufman J; Vergnolle N; Surette MG; Rioux KP
Aliment Pharmacol Ther; 2011 Aug; 34(3):374-83. PubMed ID: 21671966
[TBL] [Abstract][Full Text] [Related]
15. [Microbiota and irritable bowel syndrome].
Ducrotté P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
[TBL] [Abstract][Full Text] [Related]
16. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
[TBL] [Abstract][Full Text] [Related]
17. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives.
Salonen A; de Vos WM; Palva A
Microbiology (Reading); 2010 Nov; 156(Pt 11):3205-3215. PubMed ID: 20705664
[TBL] [Abstract][Full Text] [Related]
19. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.
Ng SC; Lam EF; Lam TT; Chan Y; Law W; Tse PC; Kamm MA; Sung JJ; Chan FK; Wu JC
J Gastroenterol Hepatol; 2013 Oct; 28(10):1624-31. PubMed ID: 23800182
[TBL] [Abstract][Full Text] [Related]
20. Probiotics in the management of functional bowel disorders: promise fulfilled?
Quigley EM
Gastroenterol Clin North Am; 2012 Dec; 41(4):805-19. PubMed ID: 23101688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
